JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

B4754 LDC000067
2 Citation

Target: Cyclin-Dependent Kinases

Summary: CDK9 inhibitor, novel and highly specific

insoluble in H2O; insoluble in EtOH; ≥18.52 mg/mL
B4976 Desogestrel

Summary: progestin used in hormonal contraceptives

insoluble in H2O; ≥13.7 mg/mL
B5835 AZD2932

Target: FLT3|VEGFR|PDGFR|c-Kit

Summary: inhibitor of VEGFR-2, PDGFRβ, Flt-3, and c-Kit

Soluble in DMSO
B5875 E3330

Summary: Ape-1/Ref-1 inhibitor

insoluble in H2O; ≥75.4 mg/mL
B5889 EGF816
2 Citation

Target: EGFR

Summary: Novel covalent inhibitor of mutant-selective EGFR

Soluble in DMSO
C3503 MS023 (hydrochloride)

Summary: type I PRMTs inhibitor

≤30 mg/mL
C4711 AM6545

Summary: CB1 selective neutral antagonist

≤10 mg/mL
C4829 UCN-02

Summary: protein kinase C inhibitor

Soluble in DMSO
C5557 SR 1824

Summary: non-agonist PPARγ ligand

≤30 mg/mL
B1200 PRX-08066

Summary: 5-HT2BR antagonist

≥20.1 mg/mL